| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |